Compare Stocks: SINT, PETV, FEMY, and BEAT

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.41 -1.0%	$0.52	$0.39 ▼ $4.00	$22.90M	-0.8	358,189 shs	274,484 shs
FEMY Femasys	$2.78 +1.5%	$3.06	$2.02 ▼ $22.20	$23.28M	-2.07	2.05 million shs	16,202 shs
PETV PetVivo	$0.68	$0.70	$0.59 ▼ $1.69	$25.83M	1.36	10,687 shs	1 shs
SINT Sintx Technologies	$1.80 -3.2%	$1.63	$1.40 ▼ $5.14	N/A	N/A	N/A	17,710 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	0.00%	-4.78%	-31.10%	-46.37%	-70.44%
FEMY Femasys	0.00%	-6.71%	+21.40%	-33.49%	-61.27%
PETV PetVivo	0.00%	0.00%	-1.45%	-14.97%	-19.85%
SINT Sintx Technologies	0.00%	+10.43%	+5.26%	-15.09%	-58.72%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BEAT HeartBeam	$0.41 -1.0%	$0.52	$0.39 ▼ $4.00	$22.90M	-0.8	358,189 shs	274,484 shs
FEMY Femasys	$2.78 +1.5%	$3.06	$2.02 ▼ $22.20	$23.28M	-2.07	2.05 million shs	16,202 shs
PETV PetVivo	$0.68	$0.70	$0.59 ▼ $1.69	$25.83M	1.36	10,687 shs	1 shs
SINT Sintx Technologies	$1.80 -3.2%	$1.63	$1.40 ▼ $5.14	N/A	N/A	N/A	17,710 shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BEAT HeartBeam	0.00%	-4.78%	-31.10%	-46.37%	-70.44%
FEMY Femasys	0.00%	-6.71%	+21.40%	-33.49%	-61.27%
PETV PetVivo	0.00%	0.00%	-1.45%	-14.97%	-19.85%
SINT Sintx Technologies	0.00%	+10.43%	+5.26%	-15.09%	-58.72%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BEAT HeartBeam	2.67	Moderate Buy	$4.00	884.25% Upside
FEMY Femasys	2.50	Moderate Buy	$50.00	1,698.56% Upside
PETV PetVivo	0.00	N/A	N/A	N/A
SINT Sintx Technologies	2.50	Moderate Buy	$9.33	418.52% Upside

Current Analyst Ratings Breakdown

Latest SINT, PETV, FEMY, and BEAT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/18/2026	FEMY Femasys	Lake Street Capital Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
8/17/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
8/14/2026	FEMY Femasys	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Lower Price Target	Buy	$10.00
7/31/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Sell (E+) ➝ Sell (D-)
7/17/2026	SINT Sintx Technologies	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)
7/16/2026	FEMY Femasys	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D-) ➝ Sell (E+)
7/14/2026	BEAT HeartBeam	Maxim Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Initiated Coverage	Buy	$2.00
7/2/2026	BEAT HeartBeam	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (E+)

(Data available from 9/13/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BEAT HeartBeam	N/A	N/A	N/A	N/A	$0.06 per share	N/A
FEMY Femasys	$2.29M	10.17	N/A	N/A	$2.01 per share	1.38
PETV PetVivo	$1.05M	24.69	N/A	N/A	($0.03) per share	-22.67
SINT Sintx Technologies	$1.02M	7.62	N/A	N/A	$0.80 per share	2.25

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BEAT HeartBeam	-$21.01M	-$0.51	N/A	N/A	N/A	N/A	-686.78%	-348.65%	11/12/2026 (Estimated)
FEMY Femasys	-$18.63M	-$3.53	N/A	N/A	N/A	-534.36%	-225.97%	-74.68%	11/17/2026 (Estimated)
PETV PetVivo	-$10.95M	-$0.34	N/A	N/A	N/A	-902.82%	-4,813.07%	-281.78%	11/12/2026 (Estimated)
SINT Sintx Technologies	-$10.36M	-$4.91	N/A	N/A	N/A	-848.20%	-354.44%	-115.37%	11/11/2026 (Estimated)

Latest SINT, PETV, FEMY, and BEAT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2026	Q2 2026	FEMY Femasys	-$1.31	-$1.33	-$0.02	-$1.33	$0.73 million	$0.33 million
8/13/2026	Q2 2026	BEAT HeartBeam	-$0.0860	-$0.10	-$0.0140	-$0.10	$0.15 million	N/A
8/11/2026	Q2 2026	SINT Sintx Technologies	-$0.73	-$0.75	-$0.02	-$0.75	$0.46 million	$0.45 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BEAT HeartBeam	N/A	N/A	N/A	N/A	N/A
FEMY Femasys	N/A	N/A	N/A	N/A	N/A
PETV PetVivo	N/A	N/A	N/A	N/A	N/A
SINT Sintx Technologies	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BEAT HeartBeam	N/A	3.66	3.61
FEMY Femasys	0.89	2.14	0.55
PETV PetVivo	0.02	0.42	0.47
SINT Sintx Technologies	N/A	2.36	1.60

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BEAT HeartBeam	7.77%
FEMY Femasys	65.27%
PETV PetVivo	24.55%
SINT Sintx Technologies	18.38%

Insider Ownership

Company	Insider Ownership
BEAT HeartBeam	17.95%
FEMY Femasys	7.75%
PETV PetVivo	10.84%
SINT Sintx Technologies	4.08%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BEAT HeartBeam	1,700	56.35 million	46.23 million	Not Optionable
FEMY Femasys	30	8.38 million	7.73 million	Not Optionable
PETV PetVivo	20	37.98 million	19.06 million	Not Optionable
SINT Sintx Technologies	40	4.32 million	4.14 million	Not Optionable

SINT, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

SINTX Technologies to Present at the H.C. Wainwright 28th Annual Global Investment Conference

September 8, 2026 | globenewswire.com

SINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the Upgrade

August 19, 2026 | zacks.com

SINTX Technologies, Inc.: SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement

August 13, 2026 | finanznachrichten.de

SINTX Technologies Regains Compliance with Nasdaq Stockholders' Equity Requirement

August 13, 2026 | globenewswire.com

SINTX Technologies, Inc.: SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth ...

August 12, 2026 | finanznachrichten.de

SiNtx Technologies, Inc. (SINT) Q2 FY2026 earnings call transcript

August 12, 2026 | finance.yahoo.com

SINTX Technologies Inc (SINT) (Q2 2026) Earnings Call Highlights: Revenue Surges 199% as ...

August 12, 2026 | finance.yahoo.com

Sintx Technologies, Inc. (SINT) Q2 2026 Earnings Call Prepared Remarks Transcript

August 11, 2026 | seekingalpha.com

SINTX Technologies Provides Mid-Year 2026 Business Update Highlighting Commercial Execution, Biomaterial Platform Expansion and Strategic Growth Initiatives

August 11, 2026 | globenewswire.com

SINTX Technologies Announces Second Quarter 2026 Earnings Release Date and Webcast

July 28, 2026 | markets.businessinsider.com

SINTX Technologies Engages Veteran MedTech Executive Chris Lyons and Southern Metrics to Establish Strategic Opportunity Management Program

July 23, 2026 | markets.businessinsider.com

SINTX Technologies Announces Receipt of More Than $3.2 Million in Contract Manufacturing Purchase Orders

June 22, 2026 | globenewswire.com

Sintx Technologies Insiders Placed Bullish Bets Worth US$644.2k

June 12, 2026 | finance.yahoo.com

SINTX Technologies Announces Raise of Approximately $5.0 Million of Capital, Including a $4.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules

June 3, 2026 | globenewswire.com

LD Micro: SINTX Technologies to Present at the LD Micro Invitational XVI Conference

May 18, 2026 | finanznachrichten.de

SINTX Technologies to Present at the LD Micro Invitational XVI Conference

May 17, 2026 | newsfilecorp.comN

Sintx Technologies (SINT) price target decreased by 25.00% to 12.24

April 15, 2026 | msn.com

HC Wainwright & Co. initiates coverage of Sintx Technologies (SINT) with buy recommendation

April 13, 2026 | msn.com

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

March 23, 2026 | globenewswire.com

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

March 19, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

SINT, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

$0.41 0.00 (-0.97%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$0.42 +0.01 (+2.36%)

As of 09/11/2026 07:56 PM Eastern

BioTelemetry, Inc., a remote medical technology company, provides remote cardiac monitoring, remote blood glucose monitoring, centralized core laboratory services for clinical trials, and original equipment manufacturing services for healthcare and clinical research customers worldwide. It operates in two segments, Healthcare and Research. The Healthcare segment focuses on the remote cardiac monitoring to identify cardiac arrhythmias or heart rhythm disorders. This segment offers mobile cardiac telemetry services; and event monitoring services, which enable physicians to prescribe wireless event, digital loop event, memory loop event, memory loop event, and non-loop event monitors. It also provides traditional and extended Holter, pacemaker, international normalized ratio, implantable loop recorder, and other implantable cardiac device monitoring services. It serves cardiologists, electrophysiologists, neurologists, and primary care physicians. The Research segment offers laboratory services, such as cardiac monitoring, imaging, scientific consulting, and data management services for drug and medical device trials. Its centralized services comprise electrocardiogram, Holter monitoring, ambulatory blood pressure monitoring, echocardiography, multigated acquisition scan, imaging, protocol development, expert reporting, and statistical analysis. It also provides support services, such as project coordination, setup and management, equipment rental, data transfer, processing, analysis, and 24/7 customer support and site training. The company also focuses on manufacturing, testing, and marketing of cardiac devices and blood glucose monitoring devices, as well as offers contract manufacturing services. BioTelemetry, Inc. was founded in 1994 and is headquartered in Malvern, Pennsylvania.

Femasys NASDAQ:FEMY

$2.78 +0.04 (+1.46%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$2.79 +0.01 (+0.43%)

As of 09/11/2026 07:50 PM Eastern

Femasys Inc., a biomedical company, develops therapeutic and diagnostic solutions to address unmet women healthcare needs worldwide. The company provides FemVue saline-air device, a contrast-generating product in the United States, Canada, Japan, and Hong Kong; FemCath, a cornual balloon catheter, a single intrauterine directional delivery product that allows for selective evaluation of an individual fallopian tube; and FemCerv, a biopsy device for endocervical curettage, which can be used to sample cervical cells and tissue circumferentially with sample containment within the device to minimize contamination. It also develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. The company offers its products to reproductive endocrinologists for infertility products, obstetrics-gynecological physicians, related healthcare professionals, and women's healthcare provider organizations. Femasys Inc. was incorporated in 2004 and is headquartered in Suwanee, Georgia.

PetVivo NASDAQ:PETV

$0.68 0.00 (0.00%)

As of 09/11/2026

PetVivo Holdings, Inc., a biomedical device company, engages in the manufacturing, commercializing, and licensing of medical devices and biomaterials for the treatment of afflictions and diseases in animals. Its lead product is Spryng, a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The company's pipeline products also include therapeutic devices for veterinary and human clinical applications. PetVivo Holdings, Inc. was founded in 2009 and is headquartered in Minneapolis, Minnesota.

Sintx Technologies NASDAQ:SINT

$1.80 -0.06 (-3.23%)

Closing price 09/11/2026 04:00 PM Eastern

Extended Trading

$1.80 -0.01 (-0.28%)

As of 09/11/2026 07:35 PM Eastern

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SINT, PETV, FEMY, and BEAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SINT, PETV, FEMY, and BEAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SINT, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SINT, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

Femasys NASDAQ:FEMY

PetVivo NASDAQ:PETV

Sintx Technologies NASDAQ:SINT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest SINT, PETV, FEMY, and BEAT Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest SINT, PETV, FEMY, and BEAT Earnings

Compare Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

SINT, PETV, FEMY, and BEAT Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

SINT, PETV, FEMY, and BEAT Company Descriptions

HeartBeam NASDAQ:BEAT

Femasys NASDAQ:FEMY

PetVivo NASDAQ:PETV

Sintx Technologies NASDAQ:SINT

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools